# Association between psychosocial factors and adverse effects of light-to-moderate ambient heat in patients with chronic diseases: results of the prospective cohort study CLIMATE-II

**Authors:** Ingmar Schäfer, Valentina Paucke, Julia Nothacker, Agata Menzel, Susanne Döpfmer, Klaus Hager, Susann Hueber, Arian Karimzadeh, Thomas Kötter, Christin Löffler, Beate S. Müller, Martin Scherer, Dagmar Lühmann

PMC · DOI: 10.1186/s12916-026-04622-4 · BMC Medicine · 2026-01-15

## TL;DR

This study found that psychosocial factors like health literacy and social support can reduce the negative effects of heat on people with chronic diseases.

## Contribution

The study is the first to show that psychosocial factors modify the impact of light-to-moderate heat on health outcomes in patients with chronic diseases.

## Key findings

- Symptom burden increased by 79% when comparing the lowest to highest heat exposure ranges.
- Better health literacy and self-efficacy were associated with lower symptom burden.
- Negative expectations and somatosensory amplification increased symptom burden during heat exposure.

## Abstract

Global temperatures are increasing. Adaptation of health behavior could mitigate adverse effects of heat, but health benefits are probably limited and depend on the context. Therefore, other strategies are also needed. Our study aimed to identify adverse effects of light heat (> 27–32 °C) and moderate heat (> 32–40 °C) and to analyze whether psychosocial factors were associated with these effects.

We conducted a prospective cohort study based on an access-restricted online survey and publicly available weather data. A total of 1810 individuals were contacted by 64 GP practices in 16 German federal states. Individuals were eligible if they were ≥ 18 years old and had ≥ 1 of 15 specific chronic diseases. Heat exposure was defined as thermal stress and operationalized by maximum temperatures and relative humidity assessed by 88 meteorological stations. Psychosocial factors were measured by standardized questionnaires assessing health literacy, self-efficacy, social support, risk expectations, and somatosensory amplification. Adverse effects of heat were operationalized by limitations in usual activities due to 14 specific symptoms reported at up to 12 follow-up assessments per participant. Data were analyzed by multivariable, multilevel, and mixed-effects linear regression.

A total of 4434 observations of 509 individuals were analyzed. Response rate was 28.1%. Participants had a mean age of 61.2 years (SD 13.7) and 240 participants (47.2%) identified themselves as women. Comparing the lowest range of heat exposure (11–15 °C) to the highest (37–40 °C), mean symptom burden increased by 79% from 3.7 (SD 5.3) to 6.7 (SD 6.0). Symptom burden was lower if participants reported better health literacy (− 0.15, 95% CI − 0.26/ − 0.05, P = 0.005), better general self-efficacy (− 0.20, 95% CI − 0.27/ − 0.14, P < 0.001), and perceived more social support (− 0.59, 95% CI − 1.07/ − 0.12, P = 0.015). Symptom burden was higher if participants reported more somatosensory amplification (0.18, 95% CI 0.13/0.24, P < 0.001) and expected a higher risk for adverse effects of heat (0.43, 95% CI 0.30/0.56, P < 0.001). We found significant effect modification (P = 0.041 through P < 0.001), indicating that the symptom burden related to light-to-moderate heat was more pronounced among patients with poorer psychosocial status.

Light-to-moderate heat was associated with adverse effects. Health literacy, self-efficacy, and social support mitigated these effects, and negative expectations and the tendency to interpret benign bodily sensations as threatening amplified them.

ClinicalTrials.gov NCT06407154.

The online version contains supplementary material available at 10.1186/s12916-026-04622-4.

## Full-text entities

- **Diseases:** Heart failure (MESH:D006333), cardiovascular disease (MESH:D002318), death (MESH:D003643), dehydration (MESH:D003681), Coronary heart disease (MESH:D003327), edema (MESH:D004487), respiratory and cardiovascular diseases (MESH:D012140), Chronic obstructive pulmonary disease (MESH:D029424), Chronic diseases (MESH:D002908), type 1 diabetes mellitus (MESH:D003922), metabolic syndrome (MESH:D024821), Diabetes mellitus (MESH:D003920), nausea (MESH:D009325), headache (MESH:D006261), dizziness (MESH:D004244), Depression (MESH:D003866), loss of consciousness (MESH:D014474), palpitations (MESH:D006331), Anxiety (MESH:D001007), circulatory problems (MESH:D012769), Cardiac arrhythmias (MESH:D001145), pain (MESH:D010146), ischemic attack (MESH:D002546), Myocardial infarction (MESH:D009203), Renal insufficiency (MESH:D051437), vomiting (MESH:D014839), shortness of breath (MESH:D004417), Schizophrenia (MESH:D012559), confusion (MESH:D003221), visual impairment (MESH:D014786), Stroke (MESH:D020521), Asthma (MESH:D001249), Symptom (MESH:D012816), fibromyalgia (MESH:D005356), chronic low back pain (MESH:D017116), Peripheral arterial occlusive disease (MESH:C564658), peripheral nervous system diseases (MESH:D010523), chronic back pain (MESH:D059350), type 2 diabetes mellitus (MESH:D003924), fatigue (MESH:D005221), muscle cramps (MESH:D009120), Neuropathy (MESH:D009422), extrasystole (MESH:D005117)
- **Chemicals:** Insulin (MESH:D007328)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12849320/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12849320/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12849320/full.md

---
Source: https://tomesphere.com/paper/PMC12849320